![](/img/cover-not-exists.png)
2123 Exposure-response (E-R) relationship of Ramucirumab (RAM) from a global, randomized, double-blind, Phase 3 study of patients (Pts) with advanced 2nd line colorectal cancer
Cohn, A. Lee, Yoshino, T., Obermannova, R., Bodoky, G., Prausova, J., Garcia-Carbonero, R., Ciuleanu, T. Eliade, Garcia-Alfonso, P., Portnoy, D.C., Van Cutsem, E., Yamazaki, K., Clingan, P.R., PolikofVolume:
51
Language:
english
Journal:
European Journal of Cancer
DOI:
10.1016/s0959-8049(16)31045-0
Date:
September, 2015
File:
PDF, 64 KB
english, 2015